Tianyin Pharmaceutical Co Stock Total Debt
Tianyin Pharmaceutical Co fundamentals help investors to digest information that contributes to Tianyin Pharmaceutical's financial success or failures. It also enables traders to predict the movement of Tianyin Stock. The fundamental analysis module provides a way to measure Tianyin Pharmaceutical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Tianyin Pharmaceutical stock.
Tianyin |
Tianyin Pharmaceutical Co Company Total Debt Analysis
Tianyin Pharmaceutical's Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.
Current Tianyin Pharmaceutical Total Debt | 2.94 M |
Most of Tianyin Pharmaceutical's fundamental indicators, such as Total Debt, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Tianyin Pharmaceutical Co is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In most industries, total debt may also include the current portion of long-term debt. Since debt terms vary widely from one company to another, simply comparing outstanding debt obligations between different companies may not be adequate. It is usually meant to compare total debt amounts between companies that operate within the same sector.
CompetitionBased on the latest financial disclosure, Tianyin Pharmaceutical Co has a Total Debt of 2.94 M. This is much higher than that of the sector and significantly higher than that of the Pharmaceutical Products industry. The total debt for all United States stocks is notably lower than that of the firm.
Tianyin Total Debt Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Tianyin Pharmaceutical's direct or indirect competition against its Total Debt to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Tianyin Pharmaceutical could also be used in its relative valuation, which is a method of valuing Tianyin Pharmaceutical by comparing valuation metrics of similar companies.Tianyin Pharmaceutical is currently under evaluation in total debt category among its peers.
Tianyin Fundamentals
| Return On Asset | -1.24 | |||
| Profit Margin | (13.72) % | |||
| Operating Margin | (7.06) % | |||
| Current Valuation | (7.22 M) | |||
| Shares Outstanding | 29.43 M | |||
| Shares Owned By Insiders | 26.44 % | |||
| Shares Owned By Institutions | 6.40 % | |||
| Number Of Shares Shorted | 112.52 K | |||
| Price To Earning | 3.34 X | |||
| Price To Book | 0.05 X | |||
| Price To Sales | 0.17 X | |||
| Revenue | 29.64 M | |||
| Gross Profit | 15.88 M | |||
| Net Income | (4.07 M) | |||
| Cash And Equivalents | 15.16 M | |||
| Cash Per Share | 0.52 X | |||
| Total Debt | 2.94 M | |||
| Debt To Equity | 0.03 % | |||
| Current Ratio | 6.64 X | |||
| Cash Flow From Operations | (1.25 M) | |||
| Earnings Per Share | (0.14) X | |||
| Number Of Employees | 1 K | |||
| Beta | 2.79 | |||
| Total Asset | 101.35 M | |||
| Retained Earnings | 50.19 M | |||
| Working Capital | 23.39 M | |||
| Current Asset | 27.53 M | |||
| Current Liabilities | 4.15 M |
Currently Active Assets on Macroaxis
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Other Consideration for investing in Tianyin Stock
If you are still planning to invest in Tianyin Pharmaceutical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Tianyin Pharmaceutical's history and understand the potential risks before investing.
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |